Search research articles
Contact Us
Filters
Showing results (121-130 of 165) with videos related to
Page
of 17
Sort By:
International Journal of Molecular Sciences
|
February 3, 2019
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Giuseppina Camiolo, Daniele Tibullo, Cesarina Giallongo, et al.
Journal of Clinical Medicine
|
July 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose
Uros Markovic, Elvira Scalisi, Giuliana Giunta, et al.
Biomolecules
|
May 6, 2020
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells
Daniele Tibullo, Cesarina Giallongo, Alessandra Romano, et al.
International Journal of Molecular Sciences
|
June 23, 2020
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3
Fabrizio Puglisi, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Frontiers in Oncology
|
March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey
Uros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real Life
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
Mariarita Spampinato, Tatiana Zuppelli, Ilaria Dulcamare, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
Scientific Reports
|
May 4, 2022
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 165) with videos related to
Sort By:
Page
of 17
International Journal of Molecular Sciences
|
February 3, 2019
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Giuseppina Camiolo, Daniele Tibullo, Cesarina Giallongo, et al.
Journal of Clinical Medicine
|
July 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose
Uros Markovic, Elvira Scalisi, Giuliana Giunta, et al.
Biomolecules
|
May 6, 2020
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells
Daniele Tibullo, Cesarina Giallongo, Alessandra Romano, et al.
International Journal of Molecular Sciences
|
June 23, 2020
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3
Fabrizio Puglisi, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Frontiers in Oncology
|
March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey
Uros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real Life
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
Mariarita Spampinato, Tatiana Zuppelli, Ilaria Dulcamare, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
Scientific Reports
|
May 4, 2022
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, et al.
Page
of 17